3-(1,3-Dioxoisoindolin-2-yl)propanenitrile

Catalog No. :
ACJDWN372
CAS No. :
3589-45-5
Molecular Formula :
C11H8N2O2
Molecular Weight :
200.20

IUPAC Name:3-(1,3-dioxoisoindolin-2-yl)propanenitrile

3-(1,3-Dioxoisoindolin-2-yl)propanenitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$153.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(1,3-Dioxoisoindolin-2-yl)propanenitrile
IUPAC Name3-(1,3-dioxoisoindolin-2-yl)propanenitrile
MDL No.MFCD00090743
Molecular FormulaC11H8N2O2
Molecular Weight200.20
SMILESN#CCCN(C(C1=C2C=CC=C1)=O)C2=O
InChI KeyLOOWMCWVRNEZLZ-UHFFFAOYSA-N
SynonymN-(2-CYANOETHYL)-PHTHALIMIDE;3-(1,3-diketoisoindolin-2-yl)propionitrile;3-(1,3-dioxo-2-isoindolinyl)propanenitrile;3-(1,3-dioxoisoindol-2-yl)propanenitrile;3-(1,3-dioxoisoindolin-2-yl)propanenitrile;CBI-BB ZERO/005454;2H-Isoindole-2-propanenitrile, 1,3-dihydro-1,3-dioxo-;N-(1,3-dioxoisoindol-2-yl)propanenitrile
CAS No.3589-45-5
PubChem CID352169

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P305+P351+P338-P337+P313-P501

Synthetic Route by SureRoute

1. ACJDWN372 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHZTP712 route compound structure diagram
    ACHZTP712574-98-1 In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACJDWN372 route product structure diagram
    ACJDWN3723589-45-5
Inquiry

2. ACJDWN372 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXACF682 route compound structure diagram
    ACXACF682109-78-4 In Stock
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACJDWN372 route product structure diagram
    ACJDWN3723589-45-5
Inquiry

Comments (0)